Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name AFAP1-AS1
   Synonyms AFAP1-AS1, AFAP1-AS, AFAP1AS, LOC84740, MGC10981
   Region GRCh38_4:7754090-7778928    Sequence
   Ensembl ENSG00000272620
   RefSeq NR_026892
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name lung cancer
   ICD-0-3 C34  
   Methods qPCR, Western blot
   Sample lung cancer tissues, cell lines (A549, H1299 ,H460)
   Expression Pattern up-regulated
   Function Description

In the current study, we found that AFAP1-AS1 was substantially over expressed in lung cancer tissues and cell lines. In addition, AFAP1-AS1 expression level was proven to be associated with the malignant features of lung cancer. Knockdown of AFAP1-AS1 significantly suppressed cell proliferation by increasing cell apoptosis and G0/G1 phase retardation of cell cycle in lung cancer cells. Furthermore, AFAP1-AS1 knockdown could suppress tumor growth of lung cancer in BALB/c nude mice. We also identified that AFAP1-AS1 silencing could influence the expression of AFAP1 and KRT1 on mRNA and protein level by cis and trans regulatory mechanism. Moreover, the oncogenic activities of AFAP1-AS1 on cell proliferation are partially mediated by KRT1.With only 10-15 % of 5-year overall survival, lung cancer accounts for more than one quarter of all cancer deaths. The most important factor for survival of lung cancer patients is the stage of the disease at diagnosis.

   Pubmed ID 29212176
   Year 2017
   Title Silencing of lncRNA AFAP1-AS1 suppressed lung cancer development by regulatory mechanism in cis and trans.
   External Links
   Links for  AFAP1-AS1 GenBank       HGNC       lncrnadb       Noncode
   Links for  lung cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.